Bristol-Myers Squibb stock trades at EUR 55.53 after Q2 beat

Published on 09/30/2026 at 11:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bristol-Myers Squibb stock was trading at EUR 55.53 at 10:59 a.m. CEST on September 30, 2026. Q2 EPS reached USD 2.04 and revenue USD 12.97 billion.

BMY, US1101221083, Illustration mit AI erstellt.

Bristol-Myers Squibb stock (ISIN US1101221083) was trading at EUR 55.53 at Lang & Schwarz at 10:59 a.m. CEST on September 30, 2026, down 0.66 percent versus the prior close of EUR 55.90. The latest reported quarter delivered EPS of USD 2.04 against a USD 1.60 consensus, putting the company back at the center of the earnings and valuation debate, according to MarketBeat on September 25, 2026.

Quarterly revenue clears estimates

For the second quarter of 2026, Bristol-Myers Squibb generated USD 12.97 billion in revenue, compared with a USD 11.74 billion consensus estimate. Revenue increased 5.70 percent year over year, while EPS exceeded expectations by USD 0.44, according to MarketBeat on September 25, 2026.

The comparison matters because newer medicines and pipeline programs are helping offset declines from mature products and patent expirations. Bristol-Myers Squibb kept fiscal 2026 EPS guidance at USD 6.75-7.00, giving the earnings beat a defined benchmark for the rest of the year.

Analysts see measured upside

MarketBeat reported on September 25, 2026, that 25 brokerages carried a Moderate Buy consensus and an average 12-month price target of USD 67.06. The target sits 6.69 percent above the USD 62.86 primary-market quote in the same report's market context, while the Lang & Schwarz reference price for German investors was EUR 55.53.

The analyst spread remains wide, from USD 64.00 to USD 82.00, showing that the pipeline opportunity and patent cycle are being valued differently. Piper Sandler raised its target from USD 75.00 to USD 82.00 on September 16, 2026, according to MarketBeat.

Dividend sets the next checkpoint

Bristol-Myers Squibb declared a quarterly dividend of USD 0.63 per share on September 16, 2026, with payment scheduled for November 2, 2026, according to MarketBeat. The annualized payout is USD 2.52, so the dividend and fiscal 2026 guidance remain the clearest dated reference points for income-oriented shareholders.

Stock trades lower in morning session

Bristol-Myers Squibb stock was trading at EUR 55.53 at Lang & Schwarz at 10:59 a.m. CEST on September 30, 2026, down 0.66 percent from the prior close of EUR 55.90 on September 29, 2026. The reference price is an intraday indication for investors in Germany rather than a closing value.